Budiani-Saberi D A, Delmonico F L
Center for Bioethics, University of Pennsylvania, Philadelphia, PA, USA.
Am J Transplant. 2008 May;8(5):925-9. doi: 10.1111/j.1600-6143.2008.02200.x.
The extent of organ sales from commercial living donors (CLDs) or vendors has now become evident. At the Second Global Consultation on Human Transplantation of the World Health Organization's (WHO) in March 2007, it was estimated that organ trafficking accounts for 5-10% of the kidney transplants performed annually throughout the world. Patients with sufficient resources in need of organs may travel from one country to another to purchase a kidney (or liver) mainly from a poor person. Transplant centers in 'destination' countries have been well known to encourage the sale of organs to 'tourist' recipients from the 'client' countries.
来自商业活体捐赠者(CLD)或器官贩子的器官买卖规模现已显现。在2007年3月世界卫生组织(WHO)召开的第二届全球人类移植协商会议上,据估计,器官 trafficking 占全球每年进行的肾移植手术的5%至10%。有足够资源的器官需求患者可能会从一个国家前往另一个国家,主要从穷人那里购买肾脏(或肝脏)。“目的地”国家的移植中心向来以鼓励向来自“客户”国家的“游客”接受者出售器官而闻名。